Evidence map›Paper›PMID 34853664›Full record

ArticleOncotarget2021

Correction: Dishevelled1-3 contribute to multidrug resistance in colorectal cancer via activating Wnt/β-catenin signaling.

Kun Zhang, Minhui Li, Houyi Huang, Linpeng Li, Jie Yang, Li Feng, Junjie Gou, Mengju Jiang, Liaotian Peng, Linyi Chen and 7 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Kun ZhangSchool of Biomedical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China.
Minhui LiSchool of Basic Medical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China.
Houyi HuangSchool of Biomedical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China.
Linpeng LiSchool of Biomedical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China.
Jie YangSchool of Biomedical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China.
Li FengSchool of Biomedical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China.
Junjie GouSchool of Biomedical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China.
Mengju JiangSchool of Biomedical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China.
Liaotian PengSchool of Biomedical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China.
Linyi ChenSchool of Biomedical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China.
Ting LiSchool of Biomedical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China.
Ping YangSchool of Basic Medical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China.
Yuhan YangSchool of Biomedical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China.
Yuanyuan WangSchool of Biomedical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China.
Quekun PengSchool of Biomedical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China.
Xiaozhen DaiSchool of Biomedical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China.
Tao ZhangSchool of Biomedical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.18632/oncotarget.23253.].

Identifiers

PMID34853664
PMCPMC8629407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.